| Interim estimates of vaccine effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines in preventing SARS-CoV-2 infection among health care personnel, first responders, and … MG Thompson MMWR. Morbidity and Mortality Weekly Report 70, 2021 | 818 | 2021 |
| Prevention and attenuation of Covid-19 with the BNT162b2 and mRNA-1273 vaccines MG Thompson, JL Burgess, AL Naleway, H Tyner, SK Yoon, J Meece, ... New England Journal of Medicine 385 (4), 320-329, 2021 | 510 | 2021 |
| Development of a definition of postacute sequelae of SARS-CoV-2 infection T Thaweethai, SE Jolley, EW Karlson, EB Levitan, B Levy, GA McComsey, ... Jama 329 (22), 1934-1946, 2023 | 245 | 2023 |
| Effectiveness of 2-dose BNT162b2 (Pfizer BioNTech) mRNA vaccine in preventing SARS-CoV-2 infection among children aged 5–11 years and adolescents aged 12–15 years—PROTECT … AL Fowlkes MMWR. Morbidity and mortality weekly report 71, 2022 | 167 | 2022 |
| Group IIA secreted phospholipase A2 is associated with the pathobiology leading to COVID-19 mortality JM Snider, JK You, X Wang, AJ Snider, B Hallmark, MM Zec, MC Seeds, ... The Journal of Clinical Investigation 131 (19), 2021 | 73 | 2021 |
| Metabolic syndrome and acute respiratory distress syndrome in hospitalized patients with COVID-19 JL Denson, AS Gillet, Y Zu, M Brown, T Pham, Y Yoshida, ... JAMA network open 4 (12), e2140568-e2140568, 2021 | 50 | 2021 |
| Interim estimate of vaccine effectiveness of BNT162b2 (Pfizer-BioNTech) vaccine in preventing SARS-CoV-2 infection among adolescents aged 12–17 years—Arizona, July–December 2021 K Lutrick MMWR. Morbidity and mortality weekly report 70, 2021 | 45 | 2021 |
| Protection with a third dose of mRNA vaccine against SARS-CoV-2 variants in frontline workers SK Yoon, KT Hegmann, MS Thiese, JL Burgess, K Ellingson, K Lutrick, ... New England Journal of Medicine 386 (19), 1855-1857, 2022 | 42 | 2022 |
| Impact of point-of-care ultrasound in the emergency department on care processes and outcomes in critically ill nontraumatic patients JM Mosier, U Stolz, R Milligan, A Roy-Chaudhury, K Lutrick, CD Hypes, ... Critical Care Explorations 1 (6), e0019, 2019 | 33 | 2019 |
| COVID-19 infection, reinfection, and vaccine effectiveness in a prospective cohort of Arizona frontline/essential workers: the AZ HEROES research protocol. K Lutrick, KD Ellingson, Z Baccam, P Rivers, S Beitel, J Parker, J Hollister, ... JMIR research protocols, 2021 | 31 | 2021 |
| Association of mRNA vaccination with clinical and virologic features of COVID-19 among US essential and frontline workers G Joseph, J Barnes, E Azziz-Baumgartner, M Arvay, A Fry, A Hall, P Kutty, ... Jama 328 (15), 1523-1533, 2022 | 27 | 2022 |
| Latinx bullying and depression in children and youth: A systematic review K Lutrick, R Clark, VL Nuño, S Bauman, S Carvajal Systematic reviews 9, 1-10, 2020 | 24 | 2020 |
| Dance for Your Health: Exploring Social Latin Dancing for Community Health Promotion JE Iuliano, K Lutrick, P Maez, E Nacim, K Reinschmidt American Journal of Health Education 48 (3), 142-145, 2017 | 17 | 2017 |
| Cutting edge: T cell responses to B. 1.1. 529 (Omicron) SARS-CoV-2 variant induced by COVID-19 infection and/or mRNA vaccination are largely preserved M Jergović, CP Coplen, JL Uhrlaub, SC Beitel, JL Burgess, K Lutrick, ... The Journal of Immunology 208 (11), 2461-2465, 2022 | 16 | 2022 |
| Incidence of SARS-CoV-2 infection among health care personnel, first responders, and other essential workers during a prevaccination COVID-19 surge in Arizona KD Ellingson, JK Gerald, X Sun, J Hollister, K Lutrick, J Parker, P Rivers, ... JAMA Health Forum 2 (10), e213318-e213318, 2021 | 16 | 2021 |
| Design of the Arizona CoVHORT: a population-based COVID-19 cohort CJ Catalfamo, KM Heslin, A Shilen, SM Khan, JR Hunsaker, E Austhof, ... Frontiers in Public Health 9, 620060, 2021 | 16 | 2021 |
| COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers K Lutrick, H Groom, AL Fowlkes, KD Groover, M Gaglani, P Rivers, ... Vaccine 40 (3), 494-502, 2022 | 12 | 2022 |
| Household transmission of influenza A viruses in 2021-2022 MA Rolfes, HK Talbot, HQ McLean, MS Stockwell, KD Ellingson, K Lutrick, ... Jama 329 (6), 482-489, 2023 | 10 | 2023 |
| Risk factors for reinfection with SARS-CoV-2 Omicron variant among previously infected frontline workers KD Ellingson, J Hollister, CJ Porter, SM Khan, LR Feldstein, AL Naleway, ... Emerging infectious diseases 29 (3), 599, 2023 | 8 | 2023 |
| Neutralizing antibody response to pseudotype severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) differs between mRNA-1273 and BNT162b2 coronavirus disease 2019 (COVID … HL Tyner, JL Burgess, L Grant, M Gaglani, JL Kuntz, AL Naleway, ... Clinical infectious diseases 75 (1), e827-e837, 2022 | 8 | 2022 |
